A new editorial was published in Oncotarget’s Volume 15 on October 1, 2024, entitled, “Transplant or no transplant for TP53 mutated AML.”
FDA commissioner says agency cannot be the only regulator of AI in digital health
(This story is from our new Health Tech newsletter. If you’d like to sign-up, just click here.) The FDA cannot regulate the use of AI
January 11, 2024